Effect of Fatty Acyl Composition for Lysophosphatidylinositol on Neuroinflammatory Responses in Primary Neuronal CulturesLysophosphatidylinositol中脂肪酸基团组成对原代神经元培养中神经炎症反应的影响JOURNAL OF MOLECULAR NEUROSCIENCEIF2.72025-03-140OA
KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in RatsJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82024-11-011OAAI
Behavioural and pharmacological effects of cannabidiol (CBD) and the cannabidiol analogue KLS-13019 in mouse models of pain and reinforcementBRITISH JOURNAL OF PHARMACOLOGYIF7.72021-05-1520OAAI
Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and PermeabilityACS MEDICINAL CHEMISTRY LETTERSIF42016-02-1558OAAI
Novel, Broad-Spectrum Anticonvulsants Containing a Sulfamide Group: Pharmacological Properties of (S)-N-[(6-Chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)JOURNAL OF MEDICINAL CHEMISTRYIF6.82013-11-1122OAAI
Novel, Broad-Spectrum Anticonvulsants Containing a Sulfamide Group: Advancement of N-((Benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into Human Clinical StudiesJOURNAL OF MEDICINAL CHEMISTRYIF6.82009-04-2337PREAI
Cathepsins B and L Differentially Regulate Amyloid Precursor Protein ProcessingJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82009-03-0134PREAI
2-amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (β-site APP cleaving enzyme):: Use of structure based design to convert a micromolar hit into a nanomolar leadJOURNAL OF MEDICINAL CHEMISTRYIF6.82007-08-08139PREAI
Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationshipsNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92007-01-0127PREAI
Neuropeptides and neuronal survival: Neuroprotective strategy for Alzheimer's diseaseNEUROPEPTIDES IN DEVELOPMENT AND AGINGIF02006-12-1721PREAI
Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptideNEUROPEPTIDES IN DEVELOPMENT AND AGINGIF02006-12-1749PREAI
Growth factor properties of VIP during early brain development -: Whole embryo culture and in vivo studiesNEUROPEPTIDES IN DEVELOPMENT AND AGINGIF02006-12-1732PREAI
Growth of the early postimplantation embryo - Regulation by high-affinity, GTP-insensitive VIP receptorsNEUROPEPTIDES IN DEVELOPMENT AND AGINGIF02006-12-172PREAI
Learning enhancement with neuropeptidesAMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYIF8.42006-04-0116PREAI
VIP neurotrophism in the central nervous system: Multiple effectors and identification of a femtomolar-acting neuroprotective peptideVIP, PACAP, AND RELATED PEPTIDES: THIRD INTERNATIONAL SYMPOSIUMIF02006-02-0741PREAI
Vasoactive intestinal peptide - Link between electrical activity and glia-mediated neurotrophismNEUROPEPTIDES: STRUCTURE AND FUNCTION IN BIOLOGY AND BEHAVIORIF02006-02-0630PREAI
Regulation of postimplantation mouse embryonic growth by maternal vasoactive intestinal peptideNEUROPEPTIDES: STRUCTURE AND FUNCTION IN BIOLOGY AND BEHAVIORIF02006-02-066PREAI
A novel signaling molecule for neuropeptide action: Activity-dependent neuroprotective proteinNEUROPEPTIDES: STRUCTURE AND FUNCTION IN BIOLOGY AND BEHAVIORIF02006-02-0664PREAI
Vasoactive intestinal peptide regulates embryonic growth through the action of activity-dependent neurotrophic factorNEUROPEPTIDES: STRUCTURE AND FUNCTION IN BIOLOGY AND BEHAVIORIF02006-02-0615OAAI
Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndromeAMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYIF8.42005-09-0152PREAI